This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Chattem, Inc.
Chattem, Inc., a prominent player in the consumer healthcare industry, is headquartered in the United States. Founded in 1879, the company has established itself as a leader in the development and marketing of over-the-counter (OTC) products, particularly in the areas of pain relief, skin care, and dietary supplements. With a diverse portfolio that includes well-known brands such as Gold Bond, Icy Hot, and Benadryl, Chattem distinguishes itself through innovative formulations and a commitment to quality. The company has achieved significant milestones, including its acquisition by Sanofi in 2010, which has further strengthened its market position. Operating primarily in North America, Chattem continues to expand its reach, delivering trusted solutions that enhance the health and well-being of consumers.
DitchCarbon Score
How does Chattem, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chattem, Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chattem, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Sanofi, which influences its climate commitments and reporting practices. While no direct emissions data is available for Chattem, Inc., it inherits climate initiatives and targets from its parent company, Sanofi. This includes participation in the Science Based Targets initiative (SBTi) and commitments to renewable energy through the RE100 initiative. These initiatives aim to align with global climate goals and promote sustainability within the industry. Chattem, Inc. is expected to adhere to the climate strategies and reduction targets set forth by Sanofi, which are designed to mitigate environmental impact and enhance corporate responsibility. However, specific reduction targets or achievements for Chattem, Inc. have not been disclosed. In summary, while Chattem, Inc. does not provide its own emissions data, it is part of a broader corporate family that is actively engaged in climate commitments through Sanofi's established initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 545,114,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 677,549,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Chattem, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
